These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26927990)

  • 1. Previous treatment, sputum-smear nonconversion, and suburban living: The risk factors of multidrug-resistant tuberculosis among Malaysians.
    Mohd Shariff N; Shah SA; Kamaludin F
    Int J Mycobacteriol; 2016 Mar; 5(1):51-8. PubMed ID: 26927990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and its influence on sputum smear positivity at the 2nd month of treatment among pulmonary tuberculosis patients in Kuala Lumpur, Malaysia: A case control study.
    Shariff NM; Safian N
    Int J Mycobacteriol; 2015 Dec; 4(4):323-9. PubMed ID: 26964816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmissibility and potential for disease progression of drug resistant
    Becerra MC; Huang CC; Lecca L; Bayona J; Contreras C; Calderon R; Yataco R; Galea J; Zhang Z; Atwood S; Cohen T; Mitnick CD; Farmer P; Murray M
    BMJ; 2019 Oct; 367():l5894. PubMed ID: 31649017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of delayed sputum smear conversion among pulmonary tuberculosis patients in Kota Kinabalu, Malaysia: A retrospective cohort study.
    Mokti K; Md Isa Z; Sharip J; Abu Bakar SN; Atil A; Hayati F; Syed Abdul Rahim SS
    Medicine (Baltimore); 2021 Aug; 100(31):e26841. PubMed ID: 34397855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
    Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis in Australia: bacteriologically-confirmed cases and drug resistance, 2011. A report of the Australian Mycobacterium Reference Laboratory Network.
    Lumb R; Bastian IB; Jelfs PJ; Keehner TJ; Pandey SK; Sievers A
    Commun Dis Intell Q Rep; 2014 Dec; 38(4):E369-75. PubMed ID: 25631600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B; Beer J; Emmrich F; Sack U; Rodloff AC
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The specific features of bacillary excretion and drug sensitivity in Mycobacterium tuberculosis in patients with recurrent pulmonary tuberculosis].
    Il'iuna TIa; Zhangireev AA; Sidorenko OA
    Probl Tuberk Bolezn Legk; 2008; (5):20-2. PubMed ID: 18711814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of treatment outcomes and drug resistance among pulmonary tuberculosis patients attending tertiary care hospitals of Kolkata, India.
    Goswami A; Chakraborty U; Mahapatra T; Mahapatra S; Mukherjee T; Das S; Das A; Dey SK; Ray S; Bhattacharya B; Pal NK
    PLoS One; 2014; 9(10):e109563. PubMed ID: 25289974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent presence of acid-fast bacilli in pulmonary tuberculosis : possible implications for developing countries.
    Gupta N
    Chest; 2000 Sep; 118(3):880-1. PubMed ID: 10988223
    [No Abstract]   [Full Text] [Related]  

  • 13. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A; Gelaw B; Wang SH; Tessema B
    PLoS One; 2018; 13(6):e0198080. PubMed ID: 29944658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.
    Kamolwat P; Nateniyom S; Chaiprasert A; Disratthakit A; Mahasirimongkol S; Yamada N; Smithtikarn S
    Trop Med Int Health; 2021 Jan; 26(1):45-53. PubMed ID: 32997863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.
    Sangare L; Diande S; Kouanda S; Dingtoumda BI; Mourfou A; Ouedraogo F; Sawadogo I; Nebie B; Gueye A; Sawadogo LT; Traore AS
    Ann Afr Med; 2010; 9(1):15-9. PubMed ID: 20418644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survey of tuberculosis drug resistance among Tibetan refugees in India.
    Salvo F; Dorjee K; Dierberg K; Cronin W; Sadutshang TD; Migliori GB; Rodrigues C; Trentini F; Di Serio C; Chaisson R; Cirillo DM
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):655-62. PubMed ID: 24903934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Second-Generation Line Probe Assay (Hain MTBDR
    Rockwood N; Wojno J; Ghebrekristos Y; Nicol MP; Meintjes G; Wilkinson RJ
    J Clin Microbiol; 2017 May; 55(5):1508-1515. PubMed ID: 28249999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.
    Cegielski JP; Dalton T; Yagui M; Wattanaamornkiet W; Volchenkov GV; Via LE; Van Der Walt M; Tupasi T; Smith SE; Odendaal R; Leimane V; Kvasnovsky C; Kuznetsova T; Kurbatova E; Kummik T; Kuksa L; Kliiman K; Kiryanova EV; Kim H; Kim CK; Kazennyy BY; Jou R; Huang WL; Ershova J; Erokhin VV; Diem L; Contreras C; Cho SN; Chernousova LN; Chen MP; Caoili JC; Bayona J; Akksilp S;
    Clin Infect Dis; 2014 Oct; 59(8):1049-63. PubMed ID: 25057101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
    Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.